| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 4: Kreitzer Anatol, Chief Discovery Officer
Sold 12,248 shares ($96K) |
| 16 Oct 2026 |
Form 4: Foff Erin Pennock, Chief Medical Officer
Sold 15,355 shares ($124K) |
| 16 Oct 2026 |
Form 4: Hanson Kristopher, General Counsel
Sold 9,020 shares ($72.9K) |
| 16 Oct 2026 |
Form 4: Lillie James Woodruff, Chief Scientific Officer
Sold 11,513 shares ($93K) |
| 16 Oct 2026 |
Form 4: Gillis Jonathan, CAO and Interim CFO
Sold 10,167 shares ($82.1K) |
| 16 Oct 2026 |
Form 4: Kroeger Christopher A., Director
Sold 73,691 shares ($595K) |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 23 Sep 2026 | EFFECT |
| 23 Sep 2026 | 424B3 |
| 18 Sep 2026 |
Form 4: Hanson Kristopher, General Counsel
Sold 16,509 shares ($193K) |
| 18 Sep 2026 | S-1/A |
| 16 Sep 2026 | 144 |
| 09 Sep 2026 | S-1 |
| 20 Aug 2026 | SCHEDULE 13G |
Loading...